Clincosm LogoSign in Get a demo

Myasthenia Gravis

Showing 26 - 50 of 102
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myasthenia Gravis Trial in Worldwide (Nipocalimab, Placebo)

Recruiting
  • Myasthenia Gravis
  • Mobile, Alabama
  • +134 more
Aug 19, 2022

Sensitivity of Repetitive Nerve Stimulation Performed in Evening

Recruiting
  • Myasthenia Gravis
    • Kraków, Lesser Poland, Poland
      Jagiellonian University Medical College, Department of Neurology
    Aug 13, 2022

    Myasthenia Gravis Trial in Saint Paul (Acupuncture)

    Recruiting
    • Myasthenia Gravis
    • Acupuncture
    • Saint Paul, Minnesota
      HealthPartners Neuroscience Center
    Jul 27, 2022

    Robotic Surgical Procedure, Thymoma, Myasthenia Gravis Trial (Da Vinci SP surgical platform)

    Not yet recruiting
    • Robotic Surgical Procedure
    • +2 more
    • Da Vinci SP surgical platform
    • (no location specified)
    Jul 8, 2022

    Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney

    Recruiting
    • Rare Disorders
    • +309 more
      • Sioux Falls, South Dakota
      • +1 more
      Jun 20, 2022

      Exercise in Autoimmune Myasthenia Gravis and Myasthenic

      Completed
      • Autoimmune Myasthenia Gravis
      • +3 more
        • Paris, France
          Online Questionnaire
        Jun 3, 2022

        Myasthenia Gravis Trial in Edmonton, Vancouver (Human normal immunoglobulin G (IgG))

        Recruiting
        • Myasthenia Gravis
        • Human normal immunoglobulin G (IgG)
        • Edmonton, Alberta, Canada
        • +1 more
        May 25, 2022

        Guillain-Barre Syndrome, Myasthenia Gravis Trial in Mansoura (diaphragmatic ultrasound)

        Completed
        • Guillain-Barre Syndrome
        • Myasthenia Gravis
        • diaphragmatic ultrasound
        • Mansoura, Not In US Or Canada, Egypt
          Mansoura University Hospitals
        May 13, 2022

        Non-adherence in Adults With Rare Disease

        Withdrawn
        • Cystic Fibrosis
        • +5 more
        • MAR-Scale
        • (no location specified)
        May 7, 2022

        Interleukin and Autoantibodies in Myasthenia Gravis.

        Not yet recruiting
        • Myasthenia Gravis
        • real time PCR , ELISA
        • (no location specified)
        Apr 27, 2022

        Myasthenia Gravis Trial in Shanghai (HBM9161 Injection (680mg), HBM9161 Drug Product (340mg))

        Not yet recruiting
        • Myasthenia Gravis
        • HBM9161 Injection (680mg)
        • HBM9161 Drug Product (340mg)
        • Shanghai, Shanghai, China
          Huashan Hospital, Fudan University
        Apr 12, 2022

        Myasthenia Gravis Trial in GuangZhou (Azathioprine, Leflunomide)

        Completed
        • Myasthenia Gravis
        • Guangzhou, Guangdong, China
          The First Affiliated Hospital, SUN YAT-SEN UNIVERSITY
        Apr 6, 2022

        Blepharoptosis, Ptosis, Eyelid, Myasthenia Gravis Trial in Boston (Magnetic Levator Prosthesis (MLP))

        Active, not recruiting
        • Blepharoptosis
        • +4 more
        • Magnetic Levator Prosthesis (MLP)
        • Boston, Massachusetts
          Schepens Eye Research Institute
        Apr 4, 2022

        Innovative Measures of Speech and Swallowing Dysfunction in

        Recruiting
        • Amyotrophic Lateral Sclerosis (ALS)
        • +4 more
          • Boston, Massachusetts
            Beth Israel Deaconess Medical Center
          Mar 10, 2022

          Predictors and Prognostic Factors of Myasthenia Gravis Outcome

          Recruiting
          • Myasthenia Gravis
          • +11 more
          • Drug treatment of myasthenia gravis and treatment of crisis
          • Assiut, Egypt
            Assiut University
          Feb 22, 2022

          Serum Auto-Antibodies in Neurological Diseases

          Enrolling by invitation
          • Multiple Sclerosis
          • +2 more
          • Blood Draw
          • Cheek swab
          • Sacramento, California
            University of California, Davis
          Jan 26, 2022

          Myasthenia Gravis, Guillain-Barre Syndrome, Multiple Sclerosis Trial in Lebanon (Current standard discharge educational

          Completed
          • Myasthenia Gravis
          • +10 more
          • Current standard discharge educational intervention
          • Personalized discharge educational intervention
          • Lebanon, New Hampshire
            Dartmouth- Hitchcock Medical Center
          Jan 6, 2022

          Myasthenia Gravis Trial in Shanghai (HBM9161 Injection (680mg), Placebos)

          Recruiting
          • Myasthenia Gravis
          • HBM9161 Injection (680mg)
          • Placebos
          • Shanghai, Shanghai, China
            Huashan Hospital, Fudan University
          Dec 15, 2021

          Burden of Disease in Myasthenia Gravis

          Completed
          • Myasthenia Gravis
            • Berlin-Mitte, Germany
              NeuroCure Clinical Research Center (NCRC), Charité University, B
            Dec 15, 2021

            Immune Profiles in Myasthenia Gravis

            Not yet recruiting
            • Myasthenia Gravis
              • (no location specified)
              Oct 13, 2021

              Myasthenia Gravis Trial in Canada, United States (RVT-1401, Placebo)

              Completed
              • Myasthenia Gravis
              • Mobile, Alabama
              • +19 more
              Oct 6, 2021

              Myasthenia Gravis Trial in Oxford

              Recruiting
              • Myasthenia Gravis
                • Oxford, United Kingdom
                  Vitaccess Ltd
                Sep 29, 2021

                Minimally Invasive Thymectomy on Subsequent Clinical Course of

                Active, not recruiting
                • Myasthenia Gravis
                • thymectomy (robotic-assisted thoracoscopic, minimally-invasive thymectomy)
                • +2 more
                • Berlin-Mitte, Germany
                • +2 more
                Sep 23, 2021

                Myasthenia Gravis, Ocular Myasthenia Gravis Trial in Beirut (Apraclonidine Hcl 0.5% Oph Soln)

                Completed
                • Myasthenia Gravis
                • Ocular Myasthenia Gravis
                • Apraclonidine Hcl 0.5% Oph Soln
                • Beirut, Lebanon
                  American University of Beirut Medical Center
                Sep 6, 2021

                Myasthenia Gravis Trial in Shanghai (HBM9161 Injection (680mg and 340 mg), Placebos, HBM9161 Injection (340 mg))

                Completed
                • Myasthenia Gravis
                • HBM9161 Injection (680mg and 340 mg)
                • +2 more
                • Shanghai, Shanghai, China
                  Huashan Hospital, Fudan University
                Sep 6, 2021